The Beauty Health Co. has released its full-year 2021 results that showed net sales were $260.1 million, as compared to $119.1 million in the previous year.
Gross profit was $181.1 million, as compared to $67.2 million in the previous year.
Net loss was $375.2 million, as compared to $29.17 million in the previous year.
Q4
Net sales in the fourth quarter of 2021 were $77.9 million, as compared to $37.9 million in the previous year.
Gross profit was $56.8 million, as compared to $23.0 million in the previous year.
Operating loss was $7.2 million, as compared to $4.7 million in 2020.
Net loss was $17.3 million, as compared to $7.5 million in 2020.
Brent Saunders, Beauty Health’s executive chairman, said, “We are extremely pleased with our accomplishments this quarter and for the full year 2021, exceeding our guidance. Importantly, we navigated through macro challenges and COVID, delivering strong results by executing against our key strategic initiatives. Our performance is proof of the compelling opportunity we have to capture the convergence of medical aesthetics and skin care.”
Andrew Stanleick, Beauty Health’s president and CEO, said, “I am grateful and honored to be leading this impressive company as CEO, especially at such an exciting time for Beauty Health. I am pleased to share that for 2022, we expect net sales in the range of $320 million to $330 million and adjusted EBITDA of approximately $50 million, barring any adverse COVID-related headwinds. 2022 will be our final year of elevated investments. In 2023, we plan to leverage our operating infrastructure to accelerate our profitability, climbing towards our historical adjusted EBITDA margin levels. We are at a pivotal point in the company’s growth trajectory, and I am thrilled to execute on our dynamic strategy."
